End-stage hip degenerative diseases
Conditions
Interventions
Control group:Quadratus lumbosum block
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients who were diagnosed with osteoarthritis of the hip, osteonecrosis of the femoral head (Ficat IIIB or IV), or developmental dysplasia of the hip (Crowe I or II). 2.Patients must have normal quadriceps strength 3.Patients must meet the American Society of Anesthesiologists (ASA) I-III functional status.
Exclusion criteria
Exclusion criteria: 1.Patients with hip ankylosis. 2.Known allergies to the drugs used in this study. 3.Opioid addiction or dependence. 4.Alcohol addiction or dependence. 5.Cognitive impairment. 6.Psychiatric illness. 7.Recognized neuromuscular disorders. 8.Previous open hip surgery 9.Other neuropathic diseases of the hip on the target side 10.An inability to communicate verbally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salvage morphine hydrochloride dosage 24 hours after operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first postoperative analgesia;Visual Analogue Scale Score;QoR -15 scale;Quadriceps strength;Range of motion;The duration of hospital stay;Incidence of postoperative complications; | — |
Countries
China
Contacts
Public ContactJYang ing
West China Hospital, Sichuan University
Outcome results
None listed